CR11545A - Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico su uso y el medicamento que lo contiene - Google Patents

Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico su uso y el medicamento que lo contiene

Info

Publication number
CR11545A
CR11545A CR11545A CR11545A CR11545A CR 11545 A CR11545 A CR 11545A CR 11545 A CR11545 A CR 11545A CR 11545 A CR11545 A CR 11545A CR 11545 A CR11545 A CR 11545A
Authority
CR
Costa Rica
Prior art keywords
steroid
carboxilico
hidroxi
acid
product containing
Prior art date
Application number
CR11545A
Other languages
English (en)
Inventor
Ulrich Klar
Joachim Kuhnke
Rolf Bohlmann
Jan Hubner
Sven Ring
Thomas Frenzel
Frederik Menges
Steffen Borden
Hans-Peter Muhn
Katja Prelle
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR11545A publication Critical patent/CR11545A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La invencion se refiere a derivados de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico de la formula quimica I, donde R4, R6a, R6b, R7, R15, R16a, R16b, R18 y Z tienen los significados indicados en la reinvindicacion 1, asi como sus solvatos, hidratos, estereoisomeros y sales.
CR11545A 2007-12-29 2010-06-29 Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico su uso y el medicamento que lo contiene CR11545A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063503A DE102007063503A1 (de) 2007-12-29 2007-12-29 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CR11545A true CR11545A (es) 2010-08-27

Family

ID=40481980

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11545A CR11545A (es) 2007-12-29 2010-06-29 Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico su uso y el medicamento que lo contiene

Country Status (22)

Country Link
US (1) US8937058B2 (es)
EP (1) EP2238151A1 (es)
JP (1) JP5600068B2 (es)
KR (1) KR20100102688A (es)
CN (1) CN101910190A (es)
AR (1) AR069966A1 (es)
AU (1) AU2008342910A1 (es)
BR (1) BRPI0821922A2 (es)
CA (1) CA2710491C (es)
CL (1) CL2008003918A1 (es)
CO (1) CO6300845A2 (es)
CR (1) CR11545A (es)
DE (1) DE102007063503A1 (es)
DO (1) DOP2010000198A (es)
EC (1) ECSP10010318A (es)
IL (1) IL206379A0 (es)
PA (1) PA8809701A1 (es)
PE (1) PE20091362A1 (es)
TW (1) TW200940073A (es)
UY (1) UY31584A1 (es)
WO (1) WO2009083266A1 (es)
ZA (1) ZA201005396B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918463A (en) 1958-06-12 1959-12-22 Searle & Co 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
US3194803A (en) * 1960-04-28 1965-07-13 Searle & Co Process and intermediates for the manufacture of 3-keto-delta4, 6 steroids
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
DE3426771C2 (de) * 1984-07-07 1997-03-20 Schering Ag 13alpha-Methylgonane, deren Herstellung und Verwendung
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4447401A1 (de) * 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Also Published As

Publication number Publication date
PE20091362A1 (es) 2009-10-15
ZA201005396B (en) 2012-01-25
IL206379A0 (en) 2010-12-30
US8937058B2 (en) 2015-01-20
AU2008342910A1 (en) 2009-07-09
CL2008003918A1 (es) 2010-01-15
KR20100102688A (ko) 2010-09-24
WO2009083266A1 (de) 2009-07-09
ECSP10010318A (es) 2010-08-31
CA2710491C (en) 2015-11-03
CN101910190A (zh) 2010-12-08
CO6300845A2 (es) 2011-07-21
TW200940073A (en) 2009-10-01
UY31584A1 (es) 2009-08-03
PA8809701A1 (es) 2009-07-23
BRPI0821922A2 (pt) 2015-06-16
DE102007063503A1 (de) 2009-07-02
JP5600068B2 (ja) 2014-10-01
DOP2010000198A (es) 2010-08-31
AR069966A1 (es) 2010-03-03
US20110021472A1 (en) 2011-01-27
JP2011507924A (ja) 2011-03-10
CA2710491A1 (en) 2009-07-09
EP2238151A1 (de) 2010-10-13

Similar Documents

Publication Publication Date Title
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
UY32611A (es) Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
SV2010003472A (es) Compuestos de pirazol
CO6400220A2 (es) Derivados de sulfonamida
UY31166A1 (es) Nuevos indazoles sustituidos, su preparación y su utilización en terapeutica
UY28763A1 (es) Compuestos de tetrazol y su uso como antagonistas del receptor de glutamato metabotrópico
CO6251367A2 (es) Derivados de 6-amino-5-aril piridina-2il-carboxamida
UY28764A1 (es) Compuestos poliheterocíclicos y su uso como antagonistas del receptor de glutamato metabotrópico
UY29339A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
SV2010003475A (es) Nuevos herbicidas
SV2009003389A (es) Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer
UA102310C2 (ru) Гетероциклические сульфонамиды, их применение и фармацевтические композиции
UY31689A1 (es) Derivados de platino-carbeno n-heterocíclico, su preparación y su aplicación en terapéutica
SV2010003514A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas
NI200900179A (es) Pirimidinil - piperazinas útiles como ligandos receptores de dopamina d3/d2.
UY32713A (es) Nuevos agentes antihelmínticos heterocíclicos y su uso.
CR11545A (es) Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico su uso y el medicamento que lo contiene
UY29733A1 (es) Piperazinas acetilenicas como antagonistas de receptores de glutamato metabotrópicos
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
ECSP109885A (es) Compuestos de cinolina para su uso en el tratamiento de la esquizofrenia
IN2012DN02698A (es)
CR11544A (es) Derivado 15,16-metilen-17-(1'-propenil)-17-3'-oxidoestra-4-3-ona, su uso y medicamento que lo contiene
CO6561812A2 (es) Derivados de 2-aldoximino-5-fluoropirimidina
NI201200103A (es) NUEVOS DERIVADOS ( HETEROCICLO - TETRAHIDRO - PIRIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y ( HETEROCICLO - DIHIDRO - PIRROLIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)